[Errata: Economic Evaluation of mFOLFOX6-based First-line Regimens for Unresectable Advanced or Recurrent Colorectal Cancer Using Clinical Decision Analysis].

[Errata: Economic Evaluation of mFOLFOX6-based First-line Regimens for Unresectable Advanced or Recurrent Colorectal Cancer Using Clinical Decision Analysis]. Yakugaku Zasshi. 2018;138(4):589 Authors: Shida T, Endo Y, Shiraishi T, Yoshioka T, Suzuki K, Kobayashi Y, Ono Y, Ito T, Inoue T PMID: 29608009 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29608009?dopt=Abstract

Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - April 4, 2018 Category: Drugs & Pharmacology Authors: Shida T, Endo Y, Shiraishi T, Yoshioka T, Suzuki K, Kobayashi Y, Ono Y, Ito T, Inoue T Tags: Yakugaku Zasshi Source Type: research

More News: Cancer | Cancer & Oncology | Colorectal Cancer | Drugs & Pharmacology | Japan Health